Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1971 1
1978 1
1980 1
1981 4
1982 2
1983 3
1984 5
1985 6
1986 5
1987 3
1988 8
1989 5
1990 2
1991 9
1992 9
1993 5
1994 8
1995 8
1996 12
1997 8
1998 15
1999 15
2000 14
2001 20
2002 20
2003 18
2004 27
2005 24
2006 20
2007 31
2008 23
2009 34
2010 33
2011 33
2012 32
2013 33
2014 39
2015 51
2016 47
2017 50
2018 49
2019 68
2020 66
2021 46
Text availability
Article attribute
Article type
Publication date

Search Results

828 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean de gil m[au] (5 results)?
Human Milk Oligosaccharides and Immune System Development.
Plaza-Díaz J, Fontana L, Gil A. Plaza-Díaz J, et al. Among authors: gil a. Nutrients. 2018 Aug 8;10(8):1038. doi: 10.3390/nu10081038. Nutrients. 2018. PMID: 30096792 Free PMC article. Review.
The importance of HMOs may be explained by their inhibitory effects on the adhesion of microorganisms to the intestinal mucosa, the growth of pathogens through the production of bacteriocins and organic acids, and the expression of genes that are involved in inflammation. …
The importance of HMOs may be explained by their inhibitory effects on the adhesion of microorganisms to the intestinal mucosa, the g …
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Sáez-Lara MJ, et al. Among authors: gil a. Int J Mol Sci. 2016 Jun 13;17(6):928. doi: 10.3390/ijms17060928. Int J Mol Sci. 2016. PMID: 27304953 Free PMC article. Review.
Select probiotics and synbiotics provided beneficial effects in patients with obesity, mainly affecting the body mass index and fat mass. Some probiotics had beneficial effects on IRS, decreasing the cell adhesion molecule-1 levels, and the synbiotics decreased the …
Select probiotics and synbiotics provided beneficial effects in patients with obesity, mainly affecting the body mass index and fat m …
Metformin for Obesity in Prepubertal and Pubertal Children: A Randomized Controlled Trial.
Pastor-Villaescusa B, Cañete MD, Caballero-Villarraso J, Hoyos R, Latorre M, Vázquez-Cobela R, Plaza-Díaz J, Maldonado J, Bueno G, Leis R, Gil Á, Cañete R, Aguilera CM. Pastor-Villaescusa B, et al. Among authors: gil a. Pediatrics. 2017 Jul;140(1):e20164285. doi: 10.1542/peds.2016-4285. Epub 2017 Jun 12. Pediatrics. 2017. PMID: 28759403 Free article. Clinical Trial.
Significant increments were observed in prepubertal children treated with metformin versus placebo recipients in the quantitative insulin sensitivity check index (0.010 and -0.007; difference, 0.017; P = .01) and the adiponectin-leptin ratio (0.96 and 0.15; difference, 0.81; P = …
Significant increments were observed in prepubertal children treated with metformin versus placebo recipients in the quantitative insulin se …
Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.
Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A. Plaza-Díaz J, et al. Among authors: gil a. Nutrients. 2017 May 28;9(6):555. doi: 10.3390/nu9060555. Nutrients. 2017. PMID: 28555037 Free PMC article. Review.
Probiotics and synbiotics are used to treat chronic diseases, principally due to their role in immune system modulation and the anti-inflammatory response. The present study reviewed the effects of probiotics and synbiotics on intestinal chronic diseases in in vitro, anima …
Probiotics and synbiotics are used to treat chronic diseases, principally due to their role in immune system modulation and the anti-inflamm …
Control of paratuberculosis: who, why and how. A review of 48 countries.
Whittington R, Donat K, Weber MF, Kelton D, Nielsen SS, Eisenberg S, Arrigoni N, Juste R, Sáez JL, Dhand N, Santi A, Michel A, Barkema H, Kralik P, Kostoulas P, Citer L, Griffin F, Barwell R, Moreira MAS, Slana I, Koehler H, Singh SV, Yoo HS, Chávez-Gris G, Goodridge A, Ocepek M, Garrido J, Stevenson K, Collins M, Alonso B, Cirone K, Paolicchi F, Gavey L, Rahman MT, de Marchin E, Van Praet W, Bauman C, Fecteau G, McKenna S, Salgado M, Fernández-Silva J, Dziedzinska R, Echeverría G, Seppänen J, Thibault V, Fridriksdottir V, Derakhshandeh A, Haghkhah M, Ruocco L, Kawaji S, Momotani E, Heuer C, Norton S, Cadmus S, Agdestein A, Kampen A, Szteyn J, Frössling J, Schwan E, Caldow G, Strain S, Carter M, Wells S, Munyeme M, Wolf R, Gurung R, Verdugo C, Fourichon C, Yamamoto T, Thapaliya S, Di Labio E, Ekgatat M, Gil A, Alesandre AN, Piaggio J, Suanes A, de Waard JH. Whittington R, et al. Among authors: gil a. BMC Vet Res. 2019 Jun 13;15(1):198. doi: 10.1186/s12917-019-1943-4. BMC Vet Res. 2019. PMID: 31196162 Free PMC article. Review.
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats.
Chaccour C, Abizanda G, Irigoyen-Barrio Á, Casellas A, Aldaz A, Martínez-Galán F, Hammann F, Gil AG. Chaccour C, et al. Among authors: gil ag. Sci Rep. 2020 Oct 13;10(1):17073. doi: 10.1038/s41598-020-74084-y. Sci Rep. 2020. PMID: 33051517 Free PMC article.
Ivermectin is a widely used antiparasitic drug with known efficacy against several single-strain RNA viruses. ...
Ivermectin is a widely used antiparasitic drug with known efficacy against several single-strain RNA viruses. ...
Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
Tenorio-Jiménez C, Martínez-Ramírez MJ, Tercero-Lozano M, Arraiza-Irigoyen C, Del Castillo-Codes I, Olza J, Plaza-Díaz J, Fontana L, Migueles JH, Olivares M, Gil Á, Gomez-Llorente C. Tenorio-Jiménez C, et al. Among authors: gil a. BMC Complement Altern Med. 2018 Nov 20;18(1):306. doi: 10.1186/s12906-018-2371-x. BMC Complement Altern Med. 2018. PMID: 30453950 Free PMC article. Clinical Trial.
The alteration of the intestinal microbiota composition has a role in the development of IRS associated with obesity, and probiotics, which are live microorganisms that confer a health benefit to the host, contribute to restore intestinal microbiota homeostasis and lower peripher …
The alteration of the intestinal microbiota composition has a role in the development of IRS associated with obesity, and probiotics, which …
828 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page